Lecture by Daniel Vasella (Novartis AG) "Healthcare: Opportunities and Challenges"

 
09.03.2014
 
University

Daniel Vasella, M.D., is Chairman of the Board of Directors for Novartis AG. He served as Chief Executive Officer (CEO) and executive member  of the Board of Directors for 14 years following the merger that created Novartis in 1996. Dr. Vasella was appointed Chairman in April 1999.

Dr. Vasella is a member  of the boards of directors  of PepsiCo,Inc., and American Express Company. He is also a member  of the International Board of Governors of
the Peres Center for Peace in Israel, the International Business Leaders Advisory Council for the Mayor of Shanghai, and is a foreign honorary  member  of the
American Academy of Arts and Sciences. He is also a member  of the Board of Trustees of the Carnegie Endowment  for International Peace. In addition,  Dr. Vasella serves as a member of several industry  associations and educational  institutions.

Before the Novartis merger, Dr. Vasella was CEO of Sandoz Pharma Ltd. and a member  of the Sandoz Group Executive Committee. From 1988  to 1992, he was with Sandoz Pharma- ceuticals Corporation  in the United States, prior  to which he held a number  of medical  positions  in Switzerland. He graduated  with an M.D. from the University of Bern in Switzerland  and completed  executive training  at the Harvard Business School in the United States. He was also awarded an honorary  doctorate  by the University of Basel.

Leadership, Biomedical Science and Global Marketing experience – former  CEO of Novartis; advisory panel member  for international organizations. Industry experience – board member  for global consumer  goods company  and global financial  services company.

Video